Does plasma phoenixin level associate with cognition? Comparison between subjective memory complaint, mild cognitive impairment, and mild Alzheimer's disease

Yuruyen M., Gultekin G., Batun G. C., Yavuzer H., Akcan F. E., Doventas A., ...Daha Fazla

INTERNATIONAL PSYCHOGERIATRICS, cilt.29, sa.9, ss.1543-1550, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 29 Sayı: 9
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1017/s1041610217000825
  • Dergi Adı: INTERNATIONAL PSYCHOGERIATRICS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), Scopus
  • Sayfa Sayıları: ss.1543-1550
  • İstanbul Üniversitesi Adresli: Evet

Özet

Background: Alteration in energy expenditure or metabolism is the most accused risk issue for the onset and for the course of neurodegenerative cognitive disorders. Neuropeptides are suggested to be related with learning and memory. Phoenixin (PNX) is the most recently reported neuropeptide and we aimed to compare the plasma level in people with subjective memory complaints, patients with mild cognitive impairment, and mild Alzheimer's disease (AD).